SHAAGtide [7317]
SHAAGtide
| SMILES | CCC(C)C(NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(N)CCSC)C(=O)NCC(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(CCSC)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C)C(=O)NC(C)C(=O)NCC(=O)O)C(C)O |
| InChIKey | ULUOXCRNSRVJPE-UHFFFAOYSA-N |
| Sequence | MLWRRKIGPQMTLSHAAG |
| HELM | PEPTIDE1{M.L.W.R.R.K.I.G.P.Q.M.T.L.S.H.A.A.G}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
SHAAGtide
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|